Self-administration of drugs through pre-filled syringes is one of the different ways that is helping patients save the fees given to a caregiver. The global connected injectable drug delivery devices market is estimated to surpass $22,814m by 2025, growing at an estimated CAGR of 6.8% from 2020 to 2025. The Europe region is the largest market for connected injectable drug delivery devices owing to the large customer pool.
Connected Injectable Drug Delivery Devices Market Outlook
Connected injectable drug delivery devices record the dosing pattern of patients and makes it available to healthcare professionals. These drug delivery devices help in addressing patient’s issues with regard to medications, treatments, and disease management protocols that are of major concern for professionals in the healthcare and pharmaceutical industries. Before bringing a connected health offering to life, it is important to understand the fundamentals of patient-centric design. One of the most successful elements in fulfilling the need for patient-centric design is human factors analysis, which benefits the patient by making injection systems more comfortable and user-friendly.
This report provides an in-depth analysis of the connected injectable drug delivery devices market by delivery devices type, connectivity technology, by disease, and by geography. On the basis of delivery devices type, the market is categorized into conventional injection devices, self-injection devices, and others. On the basis of connectivity technology, the market is segmented into wireless technology, Bluetooth, near infrared technology, and smart phone apps. Based on disease, the market is categorized into anaphylaxis, autoimmune disease, cardiovascular, diabetes, hormone replacement, and others.
Connected Injectable Drug Delivery Devices Market Growth Drivers
The market is forecast to be majorly driven by the increase in cases of chronic diseases like rheumatoid arthritis, cardiovascular disease, cancer and diabetes. The increasing concern of the pharmaceutical or medical devices companies towards development of connected injectable drug delivery devices is expected to drive the connected injectable drug delivery devices market.
Connected Injectable Drug Delivery Devices Market Challenges
The regulatory hurdles due to high requirement of data and evidences for developing new technologies and recent product recalls by the FDA are restraining the growth of the connected injectable drug delivery devices market. High cost of these connected injectable drug delivery devices and data security and privacy issues are also hindering the market growth.
Connected Injectable Drug Delivery Devices Market Research Scope
The base year of the study is 2020, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the connected injectable drug delivery devices market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to measure their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of delivery devices, and connectivity technology in the connected injectable drug delivery devices market.
Connected Injectable Drug Delivery Devices Market Report: Industry Coverage
- Delivery devices type in Connected Injectable Drug Delivery Devices: Conventional Injection Devices, Self-Injection Devices, and Others
- Connectivity technology in Connected Injectable Drug Delivery Devices: Wireless Technology, Bluetooth, Near Field Technology, and Smart Phone Apps
- Diseases in Connected Injectable Drug Delivery Devices: Anaphylaxis, Autoimmune Disease, Cardiovascular, Diabetes, Hormone Replacement, and Others
The Connected Injectable Drug Delivery Devices Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions.
The regions and countries covered in the study include:
- North America: The U.S., Canada, Mexico
- South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
- Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
- APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
- The Middle East and Africa: Israel, South Africa, Saudi Arabia
Connected Injectable Drug Delivery Devices Market Key Players Perspective
Some of the key players mentioned in this report are Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Biocorp, Haselmeier Inc., and West Pharmaceutical Services, Inc.
Connected Injectable Drug Delivery Devices Market Trends
- Rising prevalence of multiple sclerosis and rheumatoid arthritis will also impact the connected injectable drug delivery devices market.
- Rising incidence of diabetes globally will also propel the growth of the connected injectable drug delivery devices market
- Conventional injection devices accounted for the major share of the total market in 2020.
- As per analysis, the conventional injection devices segment will generate substantial revenue by 2025. The advancement in technology and rising incidences of rheumatoid arthritis and multiple sclerosis are set to drive the market in the next few years.
Table of Contents
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3.1.1. Product Benchmarking - Top 8 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 8 companies
3.1.4. Patent Analysis - Top 8 companies
3.1.5. Pricing Analysis
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
6.3.1. Conventional Injection Devices
6.3.2. Self-Injection Devices
184.108.40.206. Pen Injectors
220.127.116.11. Needle Free Injectors
18.104.22.168. Auto Injectors
7.2. Wireless Technology
7.4. Near Field Technology
7.5. Smart Phone Apps
8.3. Autoimmune Disease
8.6. Hormone Replacement
9.2. North America Market Research (Million / $Billion)
9.2.1. Segment type Size and Market Size Analysis
9.2.2. Revenue and Trends
9.2.3. Application Revenue and Trends by type of Application
9.2.4. Company Revenue and Product Analysis
9.2.5. North America Product type and Application Market Size
22.214.171.124. Rest of North America
9.3. Connected Injectable Drug Delivery Devices - South America Segment Research
9.4. South America Market Research (Market Size -$Million / $Billion)
9.4.1. Segment type Size and Market Size Analysis
9.4.2. Revenue and Trends
9.4.3. Application Revenue and Trends by type of Application
9.4.4. Company Revenue and Product Analysis
9.4.5. South America Product type and Application Market Size
126.96.36.199. Costa Rica
188.8.131.52. Rest of South America
9.5. Connected Injectable Drug Delivery Devices - Europe Segment Research
9.6. Europe Market Research (Market Size -$Million / $Billion)
9.6.1. Segment type Size and Market Size Analysis
9.6.2. Revenue and Trends
9.6.3. Application Revenue and Trends by type of Application
9.6.4. Company Revenue and Product Analysis
9.6.5. Europe Segment Product type and Application Market Size
184.108.40.206. Rest of Europe
9.7. Connected Injectable Drug Delivery Devices – APAC Segment Research
9.8. APAC Market Research (Market Size -$Million / $Billion)
9.8.1. Segment type Size and Market Size Analysis
9.8.2. Revenue and Trends
9.8.3. Application Revenue and Trends by type of Application
9.8.4. Company Revenue and Product Analysis
9.8.5. APAC Segment – Product type and Application Market Size
220.127.116.11. South Korea
10.2. M&A's, collaborations, JVs and partnerships
11.2. Ypsomed Holdings
11.3. Unolife Corporation
11.4. Quio Technologies
11.5. SHL Group
11.7. Haselmeier Inc.
11.8. West Pharmaceutical Services Inc.